Current Drug Therapy

Journal Title：Current Drug Therapy

Current Drug Therapy covers a wide range of research, including cancer, nanoparticles, liposomes, chemotherapy, bioavailability, nanotechnology, radiotherapy, Alzheimer's disease, diabetes, psoriasis, vaccines, drug resistance, oxidative stress, bevacizumab, quality from design, drug delivery, inflammation, nano medicine and other hot topics. These themes reflect the latest trends and cutting-edge research in the field of drug therapy.

This journal has a certain influence in the academic community, with an impact factor (2023) of 0.302. Although relatively low, it still plays an important role in the field of drug therapy. The papers published in journals undergo rigorous peer review to ensure their quality and academic value. In addition, the journal also emphasizes interaction with readers and authors, providing practical information such as submission experience sharing and author knowledge, which facilitates researchers to better understand and participate in the journal's submission and publication process.

《目前的药物治疗杂》的研究范围广泛，涵盖了癌症、纳米颗粒、脂质体、化疗、生物利用度、纳米技术、放射治疗、阿尔茨海默病、糖尿病、银屑病、疫苗、耐药性、氧化应激、贝伐珠单抗、质量源于设计、药物递送、炎症、纳米医学等多个热点主题。这些主题反映了当前药物疗法领域的最新趋势和前沿研究。

该期刊在学术界具有一定的影响力，其影响因子（2023年）为0.302，虽然相对较低，但仍在药物疗法领域内发挥着重要的作用。期刊上发表的论文经过严格的同行评审，确保了文章的质量和学术价值。此外，该期刊还注重与读者和作者的互动，提供了投稿经验分享、作者需知等实用信息，方便研究人员更好地了解和参与期刊的投稿和发表过程。

Current Drug Therapy由Bentham出版商出版，收稿方向涵盖PHARMACOLOGY & PHARMACY全领域，平均审稿速度 ，影响因子指数0.3，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。